Medication info
Empagagliptin 2L-Proline/Metformin Tablets 5/1000 mg

Empagagliptin 2L-Proline/Metformin Tablets 5/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›7.55mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablets
Packaging
30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202502938 · Approved 2025.11.13

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medication is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Drug Interactions under Precautions for Use). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Patients Requiring Caution under Precautions for Use, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medication should be discontinued immediately (see section 2. Patients Who Must Not Take This Medication under Precautions for Use, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Poor blood sugar control in patients with type 2 diabetes
  • cardiovascular disease
View approved original text

This medication is used in conjunction with dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. By using empagagliptin and metformin together, blood sugar can be effectively controlled. It can also provide assistance when blood sugar control is insufficient, and caution is needed when used in patients with cardiovascular disease. For some patients, consideration of the impact on cardiovascular events is essential, so it is important to receive guidance from a specialist. Overall, this medication is used to enhance blood sugar control and support diabetes management.

How to take

Adult dose

The recommended dose of this medication is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Drug Interactions under Precautions for Use). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Patients Requiring Caution under Precautions for Use, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medication should be discontinued immediately (see section 2. Patients Who Must Not Take This Medication under Precautions for Use, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is helpful in controlling blood sugar. However, it may cause a dangerous condition known as severe lactic acidosis, so caution is needed. When used with other diabetes medications, hypoglycemia may occur, so it should be used carefully. Patients with significantly impaired kidney function, acute infections, dehydration, or cardiac issues should not use this medication. Also, it is safe for pregnant or breastfeeding women to avoid this medication. Kidney function should be monitored regularly during treatment, and special caution should be taken if symptoms of dehydration or gastrointestinal discomfort occur. Urinary tract infections or genital infections may occur, so any symptoms should be reported to healthcare providers immediately. If sudden fatigue, muscle pain, difficulty breathing, or abdominal pain occurs while taking this medication, it could be a sign of lactic acidosis and immediate medical attention should be sought. It may be necessary to consult with a doctor about temporarily stopping the medication before surgery or radiological examinations. Taking this medication with alcohol can be dangerous, so it is best to avoid drinking. Elderly or patients with weak kidney function may require dose adjustments and regular monitoring. There is a risk of hypoglycemia, so caution should be exercised in skipping meals or after vigorous exercise. Monitoring vitamin B12 levels during the medication period is advisable. Following these precautions can ensure safe therapeutic effects.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • nausea
  • vomiting
Show 332 more
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disorders
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • difficulty in urination
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • necrotizing fasciitis of the perineum
  • vulvovaginal candidiasis
  • vulvitis
  • balanitis
  • fluid loss
  • increased blood creatinine
  • decreased glomerular filtration rate
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • maxillary bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colon bleed
  • appendiceal abscess
  • appendicitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • salpingeal-ovarian abscess
  • vestibular neuritis
  • headache
  • sensory loss
  • orthostatic dizziness
  • dizziness
  • weakness
  • chest discomfort
  • chest pain
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight loss
  • urinary calculi
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • insomnia
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • orthostatic vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • nasopharyngitis
  • shingles
  • drowsiness
  • facial paralysis
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • abnormal sensation
  • edema
  • pain
  • pain at the site of puncture
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual disturbances
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliolumbar ligament syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular disease
  • peripheral artery occlusive disease
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • dermal cysts
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • eye discomfort
  • eye congestion
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • tinea capitis
  • dental abscess
  • nasopharyngitis
  • upper respiratory infection
  • periodontitis
  • dental abscess
  • orthostatic dizziness
  • sensory loss
  • perceptual abnormalities
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • CNS-origin vertigo
  • headache
  • orthostatic dizziness
  • facial paralysis
  • drowsiness
  • fatigue
  • peripheral swelling
  • facial swelling
  • edema
  • chest pain
  • weight gain
  • ECG abnormalities
  • hemoglobin decrease
  • hemoglobin increase
  • positive Helicobacter test
  • positive urine red blood cells
  • ureterolithiasis
  • acute kidney injury
  • chronic kidney disease
  • hematuria
  • hypertonic bladder
  • kidney mass
  • urine retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • diabetes insipidus
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • low back pain
  • limb pain
  • musculoskeletal chest pain
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal deposit
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual disturbances
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual phlegm
  • cough
  • epistaxis
  • allergic rhinitis
  • limb injury
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliolumbar ligament syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • unstable angina
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular disease
  • peripheral artery occlusive disease
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • cholesteatoma
  • gastric cancer
  • leiomyoma
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • anxiety
  • depression
  • sleep disorders
  • anxiety
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • orthostatic dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and light, so it should be stored in a sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. By storing it this way, the effects of the medication can be safely maintained.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablets

Package unit

30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.